GNMK : Summary for GenMark Diagnostics, Inc. - Yahoo Finance

U.S. Markets open in 5 hrs 59 mins

GenMark Diagnostics, Inc. (GNMK)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
12.48+0.23 (+1.88%)
At close: 4:00PM EST
People also watch
FLDMNSTGNVDQGHDXELGX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close12.25
Open12.31
Bid0.00 x
Ask0.00 x
Day's Range12.20 - 12.56
52 Week Range4.20 - 13.43
Volume224,771
Avg. Volume289,259
Market Cap579.13M
Beta0.86
PE Ratio (TTM)-11.51
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • TheStreet.com13 days ago

    7 Stocks Making Big Moves With Unusual Volume

    Here's a technical look at how to trade stocks rising with unusual volume flow.

  • GenMark Diagnostics, Inc. – Value Analysis (NASDAQ:GNMK) : January 10, 2017
    Capital Cube14 days ago

    GenMark Diagnostics, Inc. – Value Analysis (NASDAQ:GNMK) : January 10, 2017

    Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives GenMark Diagnostics, Inc. a score of 28. Our analysis is based on comparing GenMark Diagnostics, Inc. with the following peers – QIAGEN NV, PerkinElmer, Inc., Alere Inc., Luminex Corp and Hologic, Inc. (QGEN-US, PKI-US, ALR-US, LMNX-US and HOLX-US). Investment Outlook GenMark Diagnostics, Inc. has a fundamental score ... Read more (Read more...)

  • Business Wire14 days ago

    GenMark Announces Preliminary Q4 2016 Financial Results

    GenMark Diagnostics, Inc. , a leading provider of automated, multiplex molecular diagnostic testing systems, today reported preliminary fourth quarter 2016 revenue of $14.9 million, an increase of 13% over the prior year period.